INTRA CELLULAR THERAPIES INC's ticker is and the CUSIP is 46116X951. A total of 4 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,246,518 | -51.8% | 18,200 | -51.3% | 0.00% | -100.0% |
| Q1 2024 | $2,588,080 | +107.7% | 37,400 | +114.9% | 0.00% | – |
| Q4 2023 | $1,246,188 | +59.8% | 17,400 | +20.8% | 0.00% | – |
| Q1 2023 | $779,760 | -86.1% | 14,400 | -86.4% | 0.00% | -100.0% |
| Q4 2022 | $5,620,104 | +0.8% | 106,200 | -11.4% | 0.00% | +50.0% |
| Q3 2022 | $5,574,000 | -18.1% | 119,800 | +0.4% | 0.00% | -33.3% |
| Q2 2022 | $6,810,000 | – | 119,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 752 | $562,000 | 0.05% |
| GROUP ONE TRADING, L.P. | 600,500 | $4,486,000 | 0.04% |
| SIMPLEX TRADING, LLC | 1,024 | $764,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |